Lecca Fundo Invest Direitos Creditorios (LECA11B) Cotización

Good Morning All, like this one too RVPH 1.8797 0.0797 (4.43%) 12-30-24

This mornings incredible post:
https://x.com/ABIntlGroup/status/1873748749572518301

wow talk about painting the tape............1 share,sold

nasd
10:05:52 0.0009 1 Sell 0.0009 0.001

Where there is life there is hope

No report of O/S increase for some time now. 16.8B+ remains the same as of 12/23/24 per OTC

BOPO tax loss selling some body, and nothing we can do about buying these, talk about sux

Buru nice move today over .7

erna.......................https://stockcharts.com/h-sc/ui?s=erna&p=W&b=5&g=0&id=p86431144783

Also, the price will be for 30, 60 or 90 bottles so don't we need to take capsule production max of 57K per 8 hour shift and divide by at least 30? We'd then take this and apply it to about 50% of price we see on GoodRx for a reasonable estimate for Elite revenue after pharmacy, distributor & other

Hero EXACTLY 💯 in addition to Leonberger buying up 100,000 options outright and disposing ZERO, a couple more things he could consider,

1) the latest round of Annual Incentive Comps were issued at $5 strike, and this was at a time the PPS was in 3's

2) the new C

Update - December 30: "United States Citizenship and Immigration Services (USCIS) has released processing data for EB-5 visa petitions through Q4 FY2024. The data includes the filings, approvals, denials, and pending cases of Form I-526 legacy, I-526, and I-526E petition for regional center investor

.90s +30%%

One other thing that I think you are misunderstanding: I think Treasury will end up with 80-99.9% of the final share count, i.e. after considering a junior-to-common conversion and capital raise.

I think this is the fundamental difference in theories. It's going to be exceedingly diff

He doesn’t work for the government

You sound like Dylan Hunt

https://g.co/kgs/8k8Q7aj

They have been waiting for the new formulation to weave its way through the patent and FDA approval processes.

Do we know if they have actually started the approval process with the FDA? Isn't that material information that they would need to release?

Also, I like the

.93

We may have seen the short term bottom this morning. I am changing my tactics accordingly and will be adding larger positions.

Why do we only see positive statement gains but never losses from the dishonorably discharged?

It’s just under 10% of my overall investment portfolio, but it’s about 30% of the drug/biotech portion of my portfolio.

$RELT - The acquisition began as early as March of 2023, but its more recent strategic transformation underscores ONAR's visionary drive to position the agency at the forefront of the healthcare marketing industry. As ONAR expands its expertise to new and emerging markets, Of Kos aligns with its rob

Bye bye wall 

$RELT - The acquisition began as early as March of 2023, but its more recent strategic transformation underscores ONAR's visionary drive to position the agency at the forefront of the healthcare marketing industry. As ONAR expands its expertise to new and emerging markets, Of Kos aligns with its rob

AlwaysRed,





Dropping to fill those last contracts ?


https://www.cmegroup.com/markets/metals/precious/silver.volume.html

What is our market cap now?  Seems pretty low for owning a 20mil revenue/year furniture company